SIRT1 and type 2 diabetes mellitus: Leveraging this NAA-induced suppression, the combination of STZ and NAA achieves two key objectives for T2DM modeling: downregulating PARP-1 activation to preserve residual β-cells and inhibiting SIRT1 to mimic insulin resistance.